Cetaphil is what most nurses mention. Here is what it was actually built for.
Cetaphil Moisturising Cream appears on most oncology patient information sheets in Australia. It is a sound recommendation for the right reasons. There are also reasons it may not be enough.
Why Cetaphil is recommended
Cetaphil Moisturising Cream is a gentle, fragrance-free emollient moisturiser manufactured by Galderma. Memorial Sloan Kettering names it alongside CeraVe as a recommended fragrance-free moisturiser for radiation patients. Most Australian oncology handouts list Cetaphil as an option. Pharmacists and nurses recommend it widely.
It earns these recommendations for genuine reasons. It is fragrance-free, non-comedogenic, and extremely well-tolerated on sensitive skin. It has a long record of use in clinical settings. The recommendation is not wrong.
What Cetaphil is designed for
Cetaphil Moisturising Cream is a general-purpose emollient moisturiser. Its core mechanism uses glycerine (humectant) and sweet almond oil (emollient) to reduce water loss and soften the skin surface.
Cetaphil was formulated for sensitive and dry skin broadly. It was not formulated specifically for radiation-affected skin. It appears on radiation guidelines because it is fragrance-free and well-tolerated, not because it was developed around the biological effects of radiation on sebaceous glands.
This is an important distinction for someone going through treatment, or for someone managing skin that has changed significantly with age or due to diabetes.
The mechanism gap
The reason skin becomes so persistently dry and sensitive during and after radiation is not simply that it loses water. Radiation disrupts the sebaceous glands in the treatment field. These glands produce sebum, and sebum contains palmitoleic acid. When gland function is disrupted, this fatty acid is no longer produced. The skin barrier has lost one of its structural lipid components.
Standard emollients, including Cetaphil, add back moisture and surface emollience. They do not provide the missing fatty acid.
Mac Pure uses macadamia oil as its base because macadamia oil contains 17-22% palmitoleic acid. This is the specific fatty acid that sebum depletion removes. The formulation is designed to suit skin that has experienced this type of lipid depletion, whether from radiation, from diabetes, or from the gradual decline in sebaceous gland output that comes with age.
Side by side
| Feature | Mac Pure Calm+ | Cetaphil Moisturising Cream |
|---|---|---|
| Fragrance-free | ✓ Yes | ✓ Yes |
| Palmitoleic acid (omega-7) | ✓ 17-22% (macadamia oil) | None |
| Formulated for radiation-affected skin | ✓ Yes, formulated for it | On oncology lists; general emollient formulation |
| Formulated for diabetic skin | ✓ Yes, formulated for it | General dry skin use |
| Formulated for aging/mature skin | ✓ Yes, formulated for it | General dry skin use |
| Australian made | ✓ Yes | No (manufactured offshore) |
| Mechanism | Sebum fatty acid replacement | Humectant + emollient |
Designed for what radiation specifically does to skin.
Calm+ is formulated to suit skin during and after radiation treatment. Fragrance-free, no synthetic preservatives, and suitable from the first day of treatment. Available in 250ml and 500ml.
Shop Calm+ from $29.95Mac Pure products are cosmetics, not therapeutic goods. They are not intended to treat, cure, or prevent any medical condition. Always consult your oncology team or treating clinician regarding skin care during active treatment.